The present invention includes vaccine compositions and methods for using these vaccine compositions in active immunotherapy. The vaccine compositions include allogeneic activated Thl memory cells. The compositions can also include one or more disease-related antigens. The methods include administering the vaccine compositions to provide a Thl footprint in normal individuals or patients susceptible to disease or having minimal residual disease.
